DZULKIFLI ABDUL RAZAK (PROFESSOR EMERITUS TAN SRI DATO')
RECTOR, INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA
Dzulkifli Abdul Razak (Prof. Emeritus Tan Sri Dato’) is the 6th Rector of the International Islamic University Malaysia (IIUM), also known as Universiti Islam Antarabangsa Malaysia (UIAM). He is the Immediate Past President of the International Association of Universities (IAU) based in UNESCO, Paris, after serving as the 14th President of IAU (2012-2016). He is also an Honorary Professor at University of Nottingham since 2014.
He had served as the 3rd Chairperson, Board of Directors, Universiti Sains Islam Malaysia (USIM), the 5thVice-Chancellor/President of Universiti Sains Malaysia from 2000-2011; and the World Health Organisation (WHO) Expert Advisory Panel on Drug Policy and Management (1995-2010) as well as the WHO Scientific Committee of Tobacco Product Regulation (2004-2006).
Dzul is the 1st Asian to receive the prestigious 2017 Gilbert Medal and the 7th internationally from Universitas 21, a group of renowned research intensive universities from 16 countries. He also received the 2017 Asia HRD Contribution to Society Award as recognition for people development in the academic world. Dzul is a Fellow for the Academy of Sciences Malaysia (FASc), the World Academy of Art and Science (FWAAS) and the Malaysian Institute of Malaysia (FMIM). He is also Honorary Lifetime member of Asian Academy of Management, and more recently Fellow of the World Academy of Islamic Management (FWAIM). He was awarded the 2017 Tokoh Akademik Negara (National Academic Laureate) and is a recipient of a number of Honorary Doctorates from various international universities. In October 2018, he was conferred the title Professor Emeritus from USM.
His latest contributions include the Fourth Industrial Revolution – The Leadership Dilemma (2018), and the Voicing Concern, the seventh volume of the same title comprising of his weekly column (2015-2017). Another contribution, Nurturing a Balance Person – The Leadership Challenge (2015, 2017) won the Anugerah Buku Negara 2016, and was enlisted as the 50 Best Malaysian Titles for International Rights 2017-2018. For the past 23 years, since 1995, Dzulwrites a weekly column for various Malaysia dailies on issues relating to education, health, and current events, available at www.thesundaily.my/news/coulmns/myview.
ASSOCIATE PROFESSOR BJÖRN WETTERMARK
ASSOCIATE PROFESSOR IN PHARMACOEPIDEMIOLOGY, KAROLINSKA INSTITUTE, SWEDEN
Associate Professor Björn Wettermark, M.Sc.Pharm, PhD works at the regional health board in Stockholm, where he supports decision makers with various analyses on quality of care. He is currently leading a project with the aim to implement a new national system for guidelines development and quality improvement.
Björn is also associate professor in pharmacoepidemiology at Karolinska Institutet with research focusing on drug utilization topics such as prescribing quality indicators, international comparisons of drug utilization, evaluation of prescribing doctors´ adherence to guidelines and intervention studies to promote rational use of drugs. He was the previous chair of the European Drug Utilization Research group.
PROFESSOR RUSLI ISMAIL
PROFESSOR IN SULTAN ZAINAL ABIDIN UNIVERSITY (UNISZA), MALAYSIA
Professor Rusli Ismail joined UnisZA in November 2016 as a professor at the Faculty of Medicine. Prior to UnisZA, Rusli was a professor at the Centre of Excellence for Research in AIDS at the Faculty of Medicine in University Malaya, Kuala Lumpur where he joined after leaving USM Institute for Research in Molecular Medicine. Rusli teaches clinical pharmacology and therapeutics.
His research interest is in “personalised medicine and pharmacogenetics” that grew from his work in clinical pharmacokinetics. His main focus currently is on drug use disorder and HIV especially when it pertains to methadone maintenance therapy (MMT) for opiate use disorder. Rusli has also been active in civil societies. It was when he was the Honorary Secretary of the Malaysian AIDS Councilthat he began to become especially interested in MMT, and this culminated in him helping to get the Government to redraw drug policy to include “harm reduction”. Rusli has published extensively and has been invited to many international conferences. He was recently invited by the Saudi Government to deliver a talk on “MMT in Malaysia” that was to act as a nucleus for a similar approach in Saudi for their similar problems.
PROFESSOR LIBBY ROUGHEAD
DIRECTOR OF QUALITY USE OF MEDICINES AND PHARMACY RESEARCH CENTRE, University of South Australia
Professor Libby Roughead’s research interests include quality use of medicines, medicines safety, adverse medicine events and pharmaceutical policy. Libby is a Senior Principal Research Fellow of the National Health and Medical Research Council, Director of the Quality Use of Medicines and Pharmacy Research Centre, lead investigator of the Centre of Research Excellence in Post-Marketing Surveillance of Medicines and Medical Devices, and Executive Director of a national prescriber intervention and feedback program targeting Australian general practitioners, pharmacists and veterans; Veterans’ MATES (www.veteransmates.net.au).
She is currently a member of the Australian Government Drug Utilisation Sub-Committee of the Pharmaceutical Benefits Advisory Committee, the Medication Safety Reference Group of the Australian Safety and Quality Commission. She acts as a temporary advisor to the World Health Organization.
ASSOCIATE PROFESSOR Che suraya mohd zin
KULLIYYAH OF PHARMACY, INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA
Associate Professor Che Suraya Haji Mohd Zin is currently the dean of Kulliyyah of Pharmacy, International Islamic University Malaysia (IIUM). She obtained her B Pharm (Hons) and Master in Clinical Pharmacy from University Science Malaysia and PhD in Pharmacy from The University of Queensland, Australia.
After finishing her PhD in 2008, she had taken up the post of Postdoctoral Research Associate at the Division of Social Research for Medicines and Health, University of Nottingham United Kingdom. Suraya has a wide range of research interests and is actively working on big data/large healthcare database studies, pharmacoepidemiology, opioid in non-cancer pain, drug utilization studies and clinical trials involving opioids and pain management.
DR AZUANA RAMLI
Deputy Director (Research and Development), PHARMACEUTICAL SERVICE DIVISION, MINISTRY OF HEALTH MALAYSIA
Dr Azuana Ramli is the Deputy Director (Research and Development) of the Pharmacy Policy and Strategic Planning Division in Pharmaceutical Services Division (PSD), Ministry of Health Malaysia. She received her BPharm degree from the University of Bradford, United Kingdom in 1993. She has a Post Grad Diploma in Quality Management in Healthcare, from the American University in Cairo before pursuing her Master studies in the National University Malaysia. Azuana obtained her PhD from University Kebangsaan Malaysia/ United Nations University- International Institute for Global Health (UNU-IIGH), and has extensive experience and interest in pharmacoeconomics, multi-criteria decision analysis, drug selection tools, medicines utilization and medication adherence areas.
PROFESSOR Louisa Jorm
DIRECTOR OF THE CENTRE FOR BIG DATA RESEARCH IN HEALTH, UNIVERSITY OF NEW SOUTH WALES, AUSTRALIA
Professor Louisa Jorm is the Foundation Director of the Centre for Big Data Research in Health at the University of New South Wales (UNSW), Sydney, Australia. She has spent equal periods (more than 10 years each) in senior leadership roles in government and academia, giving her unique opportunities for translational research impacts.
Professor Jorm is an international leader in health “big data” research and specifically in applying advanced analytic methods to large-scale routinely collected data, including hospital inpatient and medical and pharmaceutical claims data. She has made major scientific contributions to research in the areas of health system performance, health surveillance, data linkage and Aboriginal health.
Professor Jorm has played a leading role in the establishment of policy, infrastructure and capacity for “big data” health research in Australia, including through membership of the Australian Health Ethics Committee, and participation in the development of a framework for secondary use of My Health Record data. She led the development of the new UNSW Master of Science in Health Data Science, the first such program in the southern hemisphere. Professor Jorm has published >160 scientific papers and been awarded >$30 million in research grants. She is a high-profile advocate for more and better use of routinely collected health data for research.
HEAD OF PHARMACY DEPARTMENT, UNIVERSITAS ISLAM INDONESIA (UII)
Dr. Saepudin, PhD is a senior lecturer in clinical pharmacy and currently is head of Pharmacy Department at Universitas Islam Indonesia in Yogyakarta – Indonesia. In 2017 He held his PhD degree in clinical pharmacy and biostatistics with research on hyponatremia in patients with heart failure. Drug utilization is part of his research interest, in which he has a long experience on using ATC/DDD methodology, with focus on antibiotics and cardiovascular medicines. He has been conducting some research on trend of antibiotics and cardiovascular medicines in Indonesia, especially in primary and secondary hospitals.
MR AMRAHI BUANG
PRESIDENT, MALAYSIAN PHARMACEUTICAL SOCIETY
Mr Amrahi Buang has been the President of Malaysian Pharmaceutical Society (MPS), the recognised national professional body for pharmacists in Malaysia since 2016. He is a member of the Malaysian Pharmacy Board, Malaysian Poisons Board, National Patient Safety Council, National Antimicrobial Resistance Committee and National Tobacco Control Committee.
He has served 35 years at the University Malaya Medical Centre (UMMC), Kuala Lumpur as the Chief Pharmacist and Deputy Director (Professional). He has helped UMMC to achieve Quality Management System certification in 2002 and hospital accreditation under the Malaysian Society for Quality in Healthcare (MSQH) in 2012. Amrahi’s contribution in the field of hospital pharmacy practice in Malaysia is immense through his time at UMMC bringing the level to a world class status. Further, Amrahi is very passionate on halal pharmaceuticals and is a leading subject matter expert in this field.
He is a member of the technical committee and working committees of MS 2424:2012 – Halal Pharmaceuticals standard, the only global halal standards for pharmaceuticals; and in the technical committee for Halal Medical Devices standard, also the first in the world. Amrahi has conducted business coaching on Halal Centric Customer Service for CCM-Halal Pharmapreneur for nineteen participating community pharmacists since August 2017.